FRI0480 SCORING SYNDESMOPHYTES ON CT SPINE IMAGES OF PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS FROM THE SENSITIVE IMAGING OF AXIAL SPONDYLOARTHRITIS (SIAS) COHORT
Background: Low dose Computed Tomography (CT) could potentially be more sensitive than radiographs in the follow up of patients with axial spondyloarthritis (axSpA). Objectives: Our first goal was to develop a scoring method for the spine and test its interreader variability and frequency of progression in the various parts of the spine. Methods: Patients (pts) of the Sensitive Imaging of Axial Spondyloarthritis (SIAS) cohort fulfilled the modified New York (mNY) criteria, had ≥1 syndesmophyte in cervical or lumbar spine on radiographs and ≥1 inflammatory lesion on MRI-spine. Baseline and 2 years follow up low-dose CT scans (approximately 2-3 mSV) were performed. Syndesmophytes were scored in the coronal and sagittal planes for all "corners" per view, thus scoring 8 'quadrants' per vertebral unit (VU). Syndesmophytes were scored as absent (score 0), <50% of the intervertebral disc height (IVDH) (score 1), ≥50% of the IVDH but no bridging (score 2) or as "bridging the IDVH" (score 3). Score range 0-552. Two readers, blinded for clinical information and time order, scored the CT scans paired by patient. Scores of the 2 readers were compared using heatmaps. Interreader variability was assessed by (two-way average) ICC and smallest detectable change (SDC) for the whole spine and per segment. Results: In total, 56 pts (84% male, mean age 48.6) were included. The heatmap (fig 1) presents the similarity in basseline and change scores per reader per VU (VU on the y-axis). Ankylosis (score 3) is most prevalent in the thoracic spine, and syndesmophytes in general are least prevalent in the cervical spine. Both readers use almost the entire possible range, pick up a similar magnitude of change and have high ICCs. Most change is present in the thoracic spine. A change ≥SDC is seen in 33.9% of the patients. Conclusions: A fine-grained scoring system for CT spine was developed. Scoring syndesmophytes with good accuracy on CT images was feasible, picking up (144) Time 1 changes over a 2-year period in a high percentage of patients, especially in the thoracic spine, which is insufficiently visible on radiographs. ). However, although associations between fatigue, pain and PaGl have been examined to some extent on the group level, studies focusing on the agreement between these patient-reported measures in individual patients are missing. A better understanding of how tight the measures are bounded in individuals may improve our ability to deal with them in the daily clinic. Objectives: To examine associations on the group level and agreements on the individual patient level between fatigue, pain and PaGl as scored on visual analogue scales (VAS) in the daily clinic by patients with active spondyloarthropathy (SpA). Methods: Data on 118 SpA patients with active disease planned to initiate treatment with a biological agent were extracted from the Danish registry for biological treatment in rheumatology (DANBIO). Data included fatigue, pain and PaGl, BASDAI and BASFI assessed on VAS-scales (0-100) and age, CRP and physician global assessment. Associations between variables were examined using simple and multiple regression analysis (all mentioned variables including sex was incorporated as independent variables). Agreements between PaGl, pain and fatigue on the individual patient level was examined by Bland-Altman analyses yielding 95% lower and upper limits of agreement (LLoA and ULoA) between intra-individual assessments. The difference between the scores on the group level was expressed as the bias. Results: Mean age was 42.9±12.6 years, mean BASDAI 56.0±19.0, mean CRP mg/dL12.9 and mean PaGl 65.7±22.6. No significant differences in BASDAI, fatigue, pain, PaGl were demonstrated between men (n=76) and women. Fatigue, pain and PaGl were significantly but only moderately inter-correlated with high standard errors of estimation (SEE) Background: inflammation and, levels of inflammatory markers, CRP and other cytokines are important for enhancing insulin resistance in PsA patients. Inflammation and, levels of inflammatory markers, CRP and other inflammatory cytokines are important players for enhancement and develpoment of insulin resistance in psoriatic arthritis patients. Objectives: To investigate the relation between insulin resistance and psoriatic arthritis presence and disease activity. To investigate the relation between insulin resistance and disease activity in patients with psoriatic arthritis. Methods: Patients Inclusion criteria: all patients in this study had psoriatic arthritis with disease duration 5 years or more. All under conventional DMARDs treatment in the form of methotrexate 12.5 mg/wk, hydroxychloroquine 400mg/day. With no treatment with glucocorticoids, 3 months prior to enrollment in the study and no previous treatment with biologics. All patients were Postmenopausal females with 3 or more years since menopause. Exclusion Criteria: DM, ischemic heart disease, hypertension, or any other chronic diseases, Smoking, on medications Medications that affect blood lipids, or body composition and metabolic functions. Postmenopausal females who were on hormonal replacement therapy. it is the updated (or computer) model with nonlinear solutions, which also uses paired fasting glucose and insulin values, were calculated using the computer model (HOMA calculator version 2.2). Results: Comparing means of age, BMI, and WHR of both groups' shows no significant difference, which indicates that both groups was matched and valid for comparison. G I have significantly higher values than the control group in the laboratory parameters Insulin, CRP and Fibrinogen as p>0.05, and the insulin resistance parameters (HOMA1, HOMA2) . G I was significantly higher than the control group as p>0.05. Significant positive correlation also found between Index for Psoriatic Arthritis (DAPSA) and insulin, HOMA1, and HOMA2. Conclusions: Psoriatic arthritis is associated with increased risk of insulin resistance. PsA activity is strongly associated with developing insulin resistance in psoriatic arthritis patients. Disclosure of Interest: None declared DOI: 10.1136/annrheumdis-2017-eular.5165 
